Freedom Biosciences is a clinical stage biotechnology platform focusing on developing next-generation ketamine and psychedelic therapeutics. The co-founder and chief scientific officer, Suresh Muthukumaraswamy, is a researcher who specializes in understanding how therapies alter brain function and behavior, including investigating the potential of microdoses of LSD on brain and cognitive function.